Related references
Note: Only part of the references are listed.Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between
Gail P. Jarvik et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Prioritizing targets for precision cancer medicine
F. Andre et al.
ANNALS OF ONCOLOGY (2014)
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
Fran Supek et al.
CELL (2014)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
Rinath Jeselsohn et al.
CLINICAL CANCER RESEARCH (2014)
Physicians' Attitudes About Multiplex Tumor Genomic Testing
Stacy W. Gray et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prospective Enterprise-Level Molecular Genotyping of a Cohort of Cancer Patients
Laura E. MacConaill et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
Eliezer M. Van Allen et al.
NATURE MEDICINE (2014)
MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
Nikhil Wagle et al.
CANCER DISCOVERY (2014)
The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
Eliezer M. Van Allen et al.
CANCER DISCOVERY (2014)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record
Peter Tarczy-Hornoch et al.
GENETICS IN MEDICINE (2013)
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Robert C. Green et al.
GENETICS IN MEDICINE (2013)
Advancing Precision Medicine for Prostate Cancer Through Genomics
Sameek Roychowdhury et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Inconsistency in large pharmacogenomic studies
Benjamin Haibe-Kains et al.
NATURE (2013)
CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features
Yong Mao et al.
PLOS ONE (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing
Jason O'Rawe et al.
GENOME MEDICINE (2013)
Identifying the status of genetic lesions in cancer clinical trial documents using machine learning
Yonghui Wu et al.
BMC GENOMICS (2012)
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
Nathan T. Ihle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
Clara Montagut et al.
NATURE MEDICINE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, Condel
Abel Gonzalez-Perez et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
Phillip G. Febbo et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
Predicting the functional impact of protein mutations: application to cancer genomics
Boris Reva et al.
NUCLEIC ACIDS RESEARCH (2011)
Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor
William McLaren et al.
BIOINFORMATICS (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Cancer-Specific High-Throughput Annotation of Somatic Mutations: Computational Prediction of Driver Missense Mutations
Hannah Carter et al.
CANCER RESEARCH (2009)
Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Elizabeth A. Mittendorf et al.
CLINICAL CANCER RESEARCH (2009)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
James Bean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cancer stem cells: An old idea - A paradigm shift
MS Wicha et al.
CANCER RESEARCH (2006)
PharmGKB: The Pharmacogenetics Knowledge Base
M Hewett et al.
NUCLEIC ACIDS RESEARCH (2002)
Systematic variation in gene expression patterns in human cancer cell lines
DT Ross et al.
NATURE GENETICS (2000)
Share Paper
